Showing 1361-1370 of 10594 results for "".
Neuroanatomy For The Rest Of Us
https://reachmd.com/programs/clinicians-roundtable/neuroanatomy-for-the-rest-of-us/1529/What should every practicing physician know about neuroanatomy? Host Dr. Leslie Lundt asks Senior scientist at BHL, Dr. Stephen Dewey to review what we have learned about neuroscience since finishing medical school.Problems We Faced As Medical Students
https://reachmd.com/programs/clinicians-roundtable/problems-we-faced-as-medical-students/1052/What if your patient is violent? What if you are faced with a tyrannical colleague? Learn the answers as Dr. Ronald Goodspeed discusses his recent book, "What if? A Survival Guide for Physicians."ctDNA-Guided Immunotherapy Shows Survival Benefit in MIBC: IMvigor011 Results
https://reachmd.com/programs/project-oncology/ctdna-immunotherapy-survival-mibc-imvigor011/36307/Presented at the 2025 ESMO Congress, the IMvigor011 phase 3 trial evaluated a ctDNA-guided strategy for administering adjuvant atezolizumab in patients with muscle-invasive bladder cancer (MIBC) following radical cystectomy. Patients with high-risk pathological features were monitored using a personThe Future of Precision Medicine in COPD Care: Biomarkers, AI, and Multimodal Data
https://reachmd.com/programs/frontlines-copd/the-future-of-precision-medicine-in-copd-care-biomarkers-ai-and-multimodal-data/36471/Precision medicine in chronic obstructive pulmonary disease (COPD) care is no longer a distant goal; it’s already taking shape through examples like using eosinophil counts to guide dupilumab therapy. But as Dr. Matthew Moll explains, this is just the beginning. Tune in to hear Dr. Moll talk about hTherapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
https://reachmd.com/programs/global-neurology-academy/therapeutic-mechanism-action-moas-ms-targeting-t-and-b-cells-reset-immune-system/9533/This lecture was given live at Regional Medical Update Dinner on Current and Future Treatments educational program, which was held in select European cities. This highly-interactive live educational meeting will provide attendees with the most recent information concerning new and emerging treatmentProstate Cancer Predictability: Can We Anticipate a Patient's Risk in 25 Years?
https://reachmd.com/programs/clinicians-roundtable/prostate-cancer-predictability-can-we-anticipate-patients-risk-25-years/2987/Can you predict a man’s risk of prostate cancer 25 years in the future? The data from this study indicates that PSA levels before age 50 is an indicator of future prostate cancer. Find out more about the prospective study conducted by a team of researchers from Memorial Sloane Kettering. EpidemiologRepairing Macular Hole and Macular Pucker
https://reachmd.com/programs/revealing-retina/repairing-macular-hole-and-macular-pucker/3924/What are macular holes and macular pucker, and how do we treat these conditions? Host Dr. Roy Levit welcomes Dr. Allen Ho, professor of ophthalmology and an attending surgeon in the Retina Service at the Wills Eye Institute in Philadelphia, to discuss back-of-the-eye vitrectomy for the treatment ofAdolescents at High Risk for Psychosis
https://reachmd.com/programs/clinicians-roundtable/adolescents-at-high-risk-for-psychosis/1648/Despite recent advances in the treatment of psychotic disorders, we are often unable to prevent poor functional outcomes. Researchers are actively exploring ways to identify and treat adolescents at high risk for psychosis. Dr. Christoph Correll discusses his work in this area with host Dr. Leslie LLearning About the New Definition of MASLD
https://reachmd.com/programs/gi-insights/learning-about-the-new-definition-of-masld/15976/Why is non-alcoholic fatty liver disease now called metabolic dysfunction-associated steatotic liver disease, and how is it categorized?TORS for Sleep Apnea
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/tors-for-sleep-apnea/6416/Sleep apnea is becoming more prevalent in the population, and there are many treatment options. Host Dr. Lee Freedman talks with Dr. Erica Thaler, director of the division of otorhinolaryngology: head and neck surgery at Penn Medicine. Many patients are not willing to be treated, or not treated adeq